Press release
United States Stargardt Disease Therapeutics Market: FDA Breakthrough Designation & Fast Track | Major Companies - Kubota Pharmaceutical Holdings Co., Ltd., Stargazer Pharmaceuticals Inc., Sanofi S.A., Alkeus Pharmaceuticals Inc.
Stargardt Disease Therapeutics Market
The Global Stargardt Disease Therapeutics Market reached USD 197.1 million in 2022 and is projected to witness lucrative growth by reaching up to USD 1,385.6 million by 2031. The global Stargardt Disease Therapeutics market is expected to exhibit a CAGR of 28.8% during the forecast period (2024-2031).
The Stargardt Disease Therapeutics Market Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/stargardt-disease-therapeutics-market?ca
Stargardt disease therapeutics focus on slowing retinal degeneration and preserving vision in patients with inherited macular dystrophy. Current approaches include gene therapy, stem cell treatment, and visual cycle modulators aimed at correcting genetic defects and protecting photoreceptor cells.
Industry Recent Developments:
United States:
July 2025: Ocugen initiated its Phase 2/3 GARDian3 clinical trial for OCU410ST, a modifier gene therapy for Stargardt disease, marking a pivotal milestone in gene-agnostic retinal treatments.
October 2025: Alkeus Pharmaceuticals presented positive long-term results for its oral drug Gildeuretinol at the AAO 2025 meeting, showing slowed vision loss progression in moderate Stargardt disease patients.
Japan:
August 2025: Astellas Pharma advanced its Phase 2 trial of a complement C5 inhibitor for Stargardt disease, exploring its ability to prevent retinal degeneration through immune modulation.
September 2025: Japanese ophthalmology research centers expanded participation in multinational gene therapy trials targeting ABCA4 mutations, supporting collaboration in next-generation Stargardt disease therapeutics.
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/stargardt-disease-therapeutics-market?ca
Major Key Players:
Kubota Pharmaceutical Holdings Co., Ltd.
Stargazer Pharmaceuticals Inc
Sanofi S.A.
Alkeus Pharmaceuticals Inc
Astellas Pharma Inc.
CHABiotech CO., Ltd.
ReVision Therapeutics, Inc.
Lin BioScience, Inc.
Biogen Inc.
F. Hoffmann-La Roche AG
Segments Covered in the Stargardt Disease Therapeutics Market:
➥ By Drug Type: LBS-008, Emixustat
➥ By Age Group: Children, Adult
➥ By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
Regional Analysis:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=stargardt-disease-therapeutics-market
Chapter Outline
⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Stargardt Disease Therapeutics Market market segments, study objectives, and years considered.
⏩ Market Landscape: The competition in the Global Stargardt Disease Therapeutics Market Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.
⏩ Companies Profiles: The Global Stargardt Disease Therapeutics Market market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.
⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.
⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Stargardt Disease Therapeutics Market Market.
⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.
⏩ Research Findings: This section of the report showcases the findings and analysis of the report.
⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.
Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription
People Also Ask:
◆ How big is the Stargardt Disease Therapeutics Market in 2025?
◆ What is the projected growth rate of the Stargardt Disease Therapeutics Market through 2033?
◆ Who are the key players in the Stargardt Disease Therapeutics Market?
◆ Which region is expected to dominate the industry during the forecast period?
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Stargardt Disease Therapeutics Market: FDA Breakthrough Designation & Fast Track | Major Companies - Kubota Pharmaceutical Holdings Co., Ltd., Stargazer Pharmaceuticals Inc., Sanofi S.A., Alkeus Pharmaceuticals Inc. here
News-ID: 4232772 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
United States Translucent Concrete Market 2025: Industry Developments, Future Gr …
Translucent Concrete Market is expected to grow at a CAGR of 51.5% during the forecast period 2024-2031
According to DataM Intelligence Comprehensive Report has released its latest report on the "Translucent Concrete Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help businesses identify growth areas and build…
North America Immersion Cooling Market: Sub-1.0 PUE & Energy Efficiency Imperati …
Leander, Texas and TOKYO
North America Immersion Cooling Market is experienced to reach growth at a significant during the forecast period (2025-2032)
According to DataM Intelligence Comprehensive Report has released its latest report on the "North America Immersion Cooling Market Size 2025," providing a detailed analysis of market trends, key growth drivers, competitive landscape, and regional insights. The report includes market size (value and volume), CAGR projections, and emerging opportunities that help…
Overactive Bladder Treatment Market Growing at 3.6% CAGR During 2024-2031 | Agin …
Leander, Texas and Tokyo, Japan - Nov 17, 2025
The global overactive bladder treatment market is growing at a CAGR of 3.6% during the forecast period 2024-2031, driven by the increasing aging population susceptible to bladder control issues, rising prevalence of neurological disorders, growing patient awareness about treatment options, and ongoing innovations in minimally invasive therapies and pharmaceutical interventions for improved quality of life.
Get a Free Sample PDF Of…
Continuous Renal Replacement Therapy Market 2024-2031 | Increasing Acute Kidney …
Leander, Texas and Tokyo, Japan - Nov 17, 2025
The global continuous renal replacement therapy market is growing at a high CAGR during the forecast period 2024-2031, driven by the rising incidence of acute kidney injury in critically ill patients, increasing adoption in intensive care units, technological advancements in CRRT systems, a growing elderly population susceptible to renal complications, and expanding applications in multi-organ failure management and sepsis treatment.
Get…
More Releases for Stargardt
Stargardt Disease Market to Witness Promising Upswing by 2034, DelveInsight Fore …
The Stargardt Disease market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Stargardt Disease pipeline products will significantly revolutionize the Stargardt Disease market dynamics.
DelveInsight's "Stargardt Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Stargardt Disease, historical and forecasted epidemiology as well as the Stargardt Disease market trends in the United…
Stargardt Disease Market Growth to Accelerate in Forecast Period (2024-2034) | e …
DelveInsight's "Stargardt Disease Market Insights, Epidemiology, and Market Forecast-2034″ report offers an in-depth understanding of the Stargardt Disease, historical and forecasted epidemiology as well as the Stargardt Disease market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
Discover Key Insights into the Stargardt Disease Market with DelveInsight's In-Depth Report @ Stargardt Disease Market Size- https://www.delveinsight.com/sample-request/stargardt-disease-stgd-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Stargardt Disease Market…
Stargardt Disease Pipeline Therapeutics, Assessment, Companies, Products, Unmet …
DelveInsight's, "Stargardt Disease Pipeline Insight 2024" report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Stargardt Disease (STGD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the…
Stargardt Disease Clinical Trials, Pipeline Insights, Treatment Drugs, and Compa …
DelveInsight's, "Stargardt Disease Pipeline Insight, 2024," report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Stargardt Disease (STGD) pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Discover the latest drugs and treatment options in the Stargardt…
Stargardt Disease Pipeline, Clinical Trials, Emerging Therapies, and FDA Approva …
DelveInsight's, "Stargardt Disease Pipeline Insight 2023" report provides comprehensive insights about 18+ companies and 20+ pipeline drugs in the Stargardt Disease pipeline landscape. It covers the Stargardt Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Stargardt Disease pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Key Takeaways from…
Global Juvenile Degeneration (Stargardt Disease) Market Forecast to 2025
Juvenile Degeneration (Stargardt Disease) Market report describes the thorough and collective examination of the Juvenile Degeneration (Stargardt Disease) industry during the past, present and conjecture periods. All the business verticals like driving market situation, regional Juvenile Degeneration (Stargardt Disease) nearness, and improvement openings are clarified. Top players of the Juvenile Degeneration (Stargardt Disease) industry, their business strategies, and growth opportunities are covered in this report. A report is incomplete without…
